- Home
- GTIM vs CTXR Comparison
GTIM vs CTXR Comparison
Compare GTIM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- CTXR
- Stock Information
- Founded
- GTIM 1987
- CTXR 2007
- Country
- GTIM United States
- CTXR United States
- Employees
- GTIM 2110
- CTXR N/A
- Industry
- GTIM Restaurants
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- CTXR Health Care
- Exchange
- GTIM Nasdaq
- CTXR Nasdaq
- Market Cap
- GTIM 17.1M
- CTXR 14.6M
- IPO Year
- GTIM 1990
- CTXR N/A
- Fundamental
- Price
- GTIM $1.64
- CTXR $0.86
- Analyst Decision
- GTIM
- CTXR Strong Buy
- Analyst Count
- GTIM 0
- CTXR 3
- Target Price
- GTIM N/A
- CTXR $54.50
- AVG Volume (30 Days)
- GTIM 18.1K
- CTXR 153.2K
- Earning Date
- GTIM 07-31-2025
- CTXR 05-14-2025
- Dividend Yield
- GTIM N/A
- CTXR N/A
- EPS Growth
- GTIM 65.30
- CTXR N/A
- EPS
- GTIM 0.09
- CTXR N/A
- Revenue
- GTIM $144,322,000.00
- CTXR N/A
- Revenue This Year
- GTIM N/A
- CTXR N/A
- Revenue Next Year
- GTIM N/A
- CTXR N/A
- P/E Ratio
- GTIM $17.56
- CTXR N/A
- Revenue Growth
- GTIM 4.14
- CTXR N/A
- 52 Week Low
- GTIM $1.51
- CTXR $0.65
- 52 Week High
- GTIM $3.45
- CTXR $26.25
- Technical
- Relative Strength Index (RSI)
- GTIM 42.55
- CTXR 51.82
- Support Level
- GTIM $1.56
- CTXR $0.80
- Resistance Level
- GTIM $1.72
- CTXR $0.92
- Average True Range (ATR)
- GTIM 0.08
- CTXR 0.08
- MACD
- GTIM 0.02
- CTXR 0.03
- Stochastic Oscillator
- GTIM 61.90
- CTXR 62.41
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.